|
Volumn 11, Issue 29, 2013, Pages 4757-4763
|
Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL CHARACTERIZATION;
HYBRID COMPOUNDS;
HYBRID MOLECULES;
INHIBITORY EFFECT;
LETHAL EFFECTS;
MECHANISTIC STUDIES;
MULTIPLE MYELOMA;
REACTIVE OXYGEN SPECIES;
SYNTHESIS (CHEMICAL);
CELL DEATH;
ANTINEOPLASTIC AGENT;
CURCUMIN;
REACTIVE OXYGEN METABOLITE;
THALIDOMIDE;
APOPTOSIS;
ARTICLE;
CELL PROLIFERATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG DESIGN;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
METABOLISM;
MULTIPLE MYELOMA;
PATHOLOGY;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CURCUMIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
MOLECULAR STRUCTURE;
MULTIPLE MYELOMA;
REACTIVE OXYGEN SPECIES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THALIDOMIDE;
|
EID: 84880112882
PISSN: 14770520
EISSN: None
Source Type: Journal
DOI: 10.1039/c3ob40595h Document Type: Article |
Times cited : (52)
|
References (40)
|